Chandan Healthcare runs a wide diagnostic network in North India, offering pathology and radiology services. As of Dec 31, 2024, it has 1 flagship lab, 9 central labs, 27 satellite centers, and 300+ collection centers across 42+ cities/towns in UP and Uttarakhand. It offers 1,496 tests supported by 11 CT scanners and 4 MRI machines. In FY25 (up to Dec), it conducted ~55.79 lakh tests for 17.11 lakh patients, with 70%+ revenue from UP. It holds NABL and NABH accreditations. Revenue split: 47% from product sales, 34.22% pathology, and 18.77% radiology.
Price Band₹151 - ₹159 |
Dates10 Feb - 12 Feb |
GMP₹0 (0.00%) |
Subscriptions7.52 times |
Issue Size₹107.36 Crs |
Price Band₹151 - ₹159 |
Listing AtNSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹70.79 Cr (0.45 Cr Shares) |
Offer For Sale₹36.57 Cr (0.23 Cr Shares) |
Total Issue₹107.36 Cr (0.68 Cr Shares) |
Face Value₹10 per equity share |
Investor Category | Lot | Shares | Amount | |
---|---|---|---|---|
Retail |
Minimum
1
800
1,27,200
Maximum
1
800
1,27,200
|
|||
NII |
Minimum
2
1,600
2,54,400
|
Updated as on 12-Feb-2025 19:00:19 hrs
Investor Category | Subscription (times) | Shares Offered | Shared Bid |
---|---|---|---|
QIB | 7.58 | 12,33,600 | 93,56,800 |
NII | 19.22 | 9,25,600 | 1,77,91,200 |
Retail | 2.44 | 21,59,200 | 52,72,800 |
Employee | - | 0 | 51,200 |
Total | 7.52 | 43,18,400 | 3,24,72,000 |
The estimated Grey Market Premium of Chandan Healthcare IPO is ₹0 per share (0.00%)
1. GMPs are available for IPOs with listing dates from May 1, 2025, onwards.
2. The GMP prices displayed here reflect news related to grey market trends. We do not trade or deal in the grey market, including subject-to-rates, nor do we recommend participating in grey market trading.
Particulars | Allocation |
---|---|
QIB | Not more than 50% of net offer |
NII | Not less than 15% of net offer |
Retail | Not less than 35% of net offer |
Market Maker | 3,39,200 EQ Share |
Employee | 2,45,600 EQ Share |
Particulars | Dec-24 | Mar-24 | Mar-23 | Mar-22 |
---|---|---|---|---|
Revenue from Operations | 167.47 | 176.59 | 136.89 | 119.56 |
Profit after Tax | 17.42 | 16.36 | 3.59 | -1.09 |
Net Worth | 54.31 | 41.16 | 27.37 | 24.00 |
Total Borrowing | 51.92 | 42.01 | 21.36 | 16.58 |
Total Assets | 170.06 | 128.86 | 97.83 | 81.23 |
NAV per share (in ₹) | 27.15 | 20.58 | NA | NA |
EPS - Basic (in ₹) | 8.07 | 8.14 | 1.68 | -0.55 |
The financial information presented is on a consolidated basis
KPI | KPI |
---|---|
EBITDA | 14.78% |
PAT | 9.26% |
ROE | 47.50% |
ROCE | 35.20% |
Debt to Equity | 1.02 |
PE Ratio | 19.53 |
PB Ratio | 7.73 |
Mkt Cap (in Crs.) | 388.79 |
Particulars | Co. | Vijaya Diagnostic | Dr. Lal Pathlabs | Metropolis Healthcare |
---|---|---|---|---|
Revenue from Ops (in Crs.) | 176.59 | 547.81 | 2,226.64 | 1,207.71 |
PAT (In Crs.) | 16.36 | 119.64 | 362.29 | 128.46 |
EPS - Basic | 8.14 | 11.62 | 46.25 | 24.95 |
NAV per share | 20.58 | 64.21 | 221.61 | 214.01 |
RONW | 39.54% | 19.91% | 20.61% | 12.33% |
EBITDA Margin | 14.78% | 39.95% | 27.36% | 23.40% |
PAT Margin | 9.26% | 21.84% | 16.27% | 10.64% |
Price to earning (PE) | 19.53 | 87.75 | 62.34 | 72.18 |
Debt to Equity | 1.02 | 0.39 | 0.05 | 0.00 |
Particulars | Co. |
---|---|
Revenue from Ops (in Crs.) | 176.59 |
PAT (In Crs.) | 16.36 |
EPS - Basic | 8.14 |
NAV per share | 20.58 |
RONW | 39.54% |
EBITDA Margin | 14.78% |
PAT Margin | 9.26% |
Price to earning (PE) | 19.53 |
Debt to Equity | 1.02 |
Vijaya Diagnostic | Dr. Lal Pathlabs | Metropolis Healthcare |
---|---|---|
547.81 | 2,226.64 | 1,207.71 |
119.64 | 362.29 | 128.46 |
11.62 | 46.25 | 24.95 |
64.21 | 221.61 | 214.01 |
19.91% | 20.61% | 12.33% |
39.95% | 27.36% | 23.40% |
21.84% | 16.27% | 10.64% |
87.75 | 62.34 | 72.18 |
0.39 | 0.05 | 0.00 |
Name | Shareholding |
---|---|
Amar Singh | 11.60% |
Amaranita Holdings (India) Private Limited | 29.22% |
Vinay Lamba | 7.92% |
Other Promoters | 21.22% |
Name | Designation |
---|---|
Amar Singh | Chairman & MD |
Asmita Singh | MD |
Rajeev Nain, | CFO |
Name : Chandan Healthcare Limited
Address : Biotech Park, Sector G, Jankipuram, Kursi Road, Lucknow- 226021, Uttar Pradesh, India
Number : +91 8429024430
Email : secretarial@chandan.co.in
Website : www.chandandiagnostic.com
Find answers to common questions that come in your mind related to IPO.
Chandan Healthcare IPO is a SME IPO having an issue size of Rs. ₹107.36 Crs. Chandan Healthcare IPO is priced at ₹151 - ₹159 per share. The issue opens on 10 Feb 25 and closes on 12 Feb 25.
Chandan Healthcare IPO opens on 10 Feb 25 and closes on 12 Feb 25.
The estimated Grey Market Premium of Chandan Healthcare IPO is ₹0 per share (0.00%).
The minimum lot size of Chandan Healthcare IPO is 800 shares & the minimum application amount is Rs. 127200.
The allotment date of Chandan Healthcare IPO is 13 Feb 25.
The listing date of Chandan Healthcare IPO is 17 Feb 25.
Chandan Healthcare IPO is subscribed 7.52 times.
Chandan Healthcare IPO is priced at ₹151 - ₹159 per share.
Click the allotment link on Chandan Healthcare IPO page of IPO360.